Institution statistics

GENIBET - BIOPHARMACEUTICALS SA - Portugal 

Ranking results:

Past rankings:
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 8.391.240 861.250 1
2017 0 10.599.993 108.993 1
2015 0 5.825.580 705.250 1
2013 0 5.986.903 1.541.187 1
2012 0 6.549.575 601.945 2
2008 0 2.984.999 271.364 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA6
AFFILOGIC SAS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA2
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITAT AUTONOMA DE BARCELONA2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
AQUAPORIN AS1
ASA SPEZIALENZYME1
ATRC AURIGON TOXICOLOGIAI KUTATOKOZPONT KORLATOLT FELELOSSEGU TARSASAG1
AZIENDA SPECIALE INNOVHUB STAZIONI SPERIMENTALI PER L'INDUSTRIA1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
CANCER RESEARCH UK1
CEINGE BIOTECNOLOGIE AVANZATE SCARL1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DEPARTMENT OF HEALTH1
EATRIS ERIC1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELAN PHARMA INTERNATIONAL LIMITED1
EUROPEAN CROHN S AND COLITIS ORGANISATION1
EUROPEAN VACCINE INITIATIVE EWIV1
FERRING PHARMACEUTICALS AS1
FIRALIS SAS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
GLAXOSMITHKLINE VACCINES1
HOSPICES CANTONAUX CHUV1
INSERM TRANSFERT1
INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES1
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT1
INSTRUCT ACADEMIC SERVICES LIMITED1
INTESTINAL BIOTECH DEVELOPMENT1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER1
LUNDS UNIVERSITET1
MERCK KGAA1
MINISTERIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT1
MOLECULES OF MAN AB1
SCLAVO VACCINES ASSOCIATION1
STATENS SERUM INSTITUT1
STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF NOTTINGHAM1
UNIVERSIDAD DE BUENOS AIRES1
UNIVERSIDADE NOVA DE LISBOA1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITAET LEIPZIG1
UNIVERSITE DE GENEVE1
UNIVERSITE DE LAUSANNE1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITE LOUIS PASTEUR STRASBOURG 11
UNIVERSITEIT ANTWERPEN1
UNIVERSITEIT GENT1
UNIVERSITEIT LEIDEN1
UNIVERSITY OF GLASGOW1
VACCINE FORMULATION INSTITUTE LIMITED1
VAKZINE PROJEKT MANAGEMENT1
WAGENINGEN UNIVERSITY1
Constancy:

Total number of partners:76

Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 70

Frequent / Rare Partner Ratio: 0.09

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES2
INDUSTRY AND TECHNOLOGY1
RTD HORIZONTAL TOPICS1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-06-01Vaccine for prevention and treatment of Trypanosoma cruzi infection CRUZIVAXparticipant8.391.24011
2017-05-01European Vaccine Research and Development Infrastructure TRANSVAC2participant10.599.99326
2015-03-01Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes DiViNeparticipant5.825.5806
2013-01-01Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial HEPAMABparticipant5.986.9037
2012-11-01"From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV" BRAINVECTORSparticipant1.597.78312
2012-01-01Scaffolds for alternative delivery SADELparticipant4.951.79210
2008-10-01Nonhuman adenovirus vectors for gene transfer to the brain BRAINCAVparticipant2.984.99911

Alias institution names:
  • GENIBET BIOPHARMACEUTICALS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum